Integral Ad Science (NASDAQ:IAS) Price Target Cut to $11.00 by Analysts at Raymond James

Integral Ad Science (NASDAQ:IAS) had its price objective trimmed by Raymond James from $16.00 to $11.00 in a research report released on Monday,Benzinga reports. The firm currently has an outperform rating on the stock.

A number of other equities analysts have also recently issued reports on the company. Benchmark reaffirmed a “hold” rating on shares of Integral Ad Science in a report on Friday, February 28th. Oppenheimer reissued an “outperform” rating on shares of Integral Ad Science in a research note on Friday, February 28th. Baird R W cut Integral Ad Science from a “strong-buy” rating to a “hold” rating in a report on Friday, March 28th. Morgan Stanley lowered their price target on shares of Integral Ad Science from $13.50 to $12.50 and set an “equal weight” rating for the company in a report on Thursday, April 17th. Finally, Barclays reduced their price objective on shares of Integral Ad Science from $14.00 to $7.00 and set an “equal weight” rating on the stock in a research note on Monday, April 21st. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $13.15.

Integral Ad Science Stock Down 0.1 %

Shares of NASDAQ IAS opened at $7.24 on Monday. The company has a market cap of $1.19 billion, a price-to-earnings ratio of 36.20, a PEG ratio of 1.06 and a beta of 1.55. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07. Integral Ad Science has a 12 month low of $6.26 and a 12 month high of $13.62. The stock has a 50-day moving average price of $8.08 and a two-hundred day moving average price of $9.82.

Integral Ad Science (NASDAQ:IAS) last released its quarterly earnings data on Friday, February 28th. The company reported $0.09 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.03). The company had revenue of $153.00 million for the quarter, compared to analyst estimates of $148.83 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. Integral Ad Science’s revenue for the quarter was up 13.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.06 earnings per share. As a group, analysts forecast that Integral Ad Science will post 0.26 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Lisa Utzschneider sold 8,547 shares of the stock in a transaction on Monday, April 7th. The stock was sold at an average price of $6.85, for a total value of $58,546.95. Following the transaction, the chief executive officer now directly owns 341,271 shares in the company, valued at $2,337,706.35. This trade represents a 2.44 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Over the last 90 days, insiders have sold 77,855 shares of company stock worth $574,587. Company insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Integral Ad Science by 4.6% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 41,519 shares of the company’s stock worth $433,000 after acquiring an additional 1,832 shares during the last quarter. Jennison Associates LLC raised its stake in shares of Integral Ad Science by 3.3% in the fourth quarter. Jennison Associates LLC now owns 63,538 shares of the company’s stock worth $663,000 after purchasing an additional 2,046 shares during the last quarter. Oppenheimer & Co. Inc. lifted its holdings in shares of Integral Ad Science by 8.0% in the fourth quarter. Oppenheimer & Co. Inc. now owns 28,040 shares of the company’s stock valued at $293,000 after purchasing an additional 2,069 shares in the last quarter. Envestnet Asset Management Inc. boosted its position in shares of Integral Ad Science by 7.4% during the fourth quarter. Envestnet Asset Management Inc. now owns 31,807 shares of the company’s stock valued at $332,000 after buying an additional 2,188 shares during the last quarter. Finally, Arizona State Retirement System grew its holdings in Integral Ad Science by 12.5% during the fourth quarter. Arizona State Retirement System now owns 23,404 shares of the company’s stock worth $244,000 after buying an additional 2,601 shares in the last quarter. 95.78% of the stock is owned by institutional investors.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.